One of the billionaire's investments has become a linchpin in the day-to-day machinery of Trump’s immigration enforcement ...

President Donald Trump is aiming to ramp up scrutiny on pharmaceutical ads — both on TV and social media — as his administration accuses companies of misleading the public about medications and their ...

The Trump administration announced a crackdown on pharmaceutical advertising on television and social media platforms, potentially disrupting billions of dollars in annual ad spending. President ...

One of the most powerful tools for competitive intel sits right inside your Google Ads account: the Auction Insights report. As long as you’re spending money on Search and Shopping, you can get an ...

Cybercriminals are running ads that promise free access to TradingView Premium, a market tracking and investment app, for Android mobile users. The links go to a cloned website, which initiates a ...

As Google Ads leans further into AI-driven automation, savvy advertisers are looking for ways to stay in control – ensuring that automation truly drives efficient results. Yet, the data available ...

Anne Marie D. Lee is an editor for CBS MoneyWatch. She writes about topics including personal finance, the workplace, travel and social media. Advertisers shelled out close to $8 million on average ...

Food and Drug Administration Commissioner Dr. Marty Makary discusses the recent decision to approve updated Covid-19 vaccines for a smaller population. In an interview with host Ryan Knutson, Makary ...

How can startups and developers actually monetize their AI products? A startup called Koah, which recently raised $5 million in seed funding, is betting that ads will be a big part of the answer. If ...

As the NFL’s popular “RedZone” pop-up TV service enters its 17th season, it drew attention this week for anticipation it will layer in commercials after nearly two decades of being “commercial-free.” ...

President Donald Trump signed a memo on Sept. 9 to increase enforcement actions against companies that use direct-to-consumer pharmaceutical advertisements and do not adequately disclose side effects ...